human papillomavirus type 18 l1 protein
SpainDrugs containing this active substance
-
This vaccine is used to protect individuals from 9 years of age against diseases caused by human papillomavirus (HPV) types 16 and 18, including cervical cancer, anal cancer, and precancerous lesions of the vulva, vagina, and anus.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage human papillomavirus type 16 l1 protein 20 µg human papillomavirus type 18 l1 protein 20 µg Manufacturer: Glaxosmithkline Biologicals
-
It is used to prevent diseases caused by 9 types of Human Papillomavirus (HPV), including precancerous lesions and cancers of the female genitals (cervix, vulva, and vagina), precancerous lesions and cancers of the anus, and genital warts in both men and women.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage human papillomavirus type 16 l1 protein 60 µg human papillomavirus type 6 protein l1 30 µg human papillomavirus type 18 l1 protein 40 µg human papillomavirus type 31 l1 protein 20 µg human papillomavirus type 11 l1 protein 40 µg human papillomavirus type 33 l1 protein 20 µg human papillomavirus type 45 l1 protein 20 µg human papillomavirus type 52 l1 protein 20 µg human papillomavirus type 58 l1 protein 20 µg Manufacturer: Merck Sharp & Dohme B.V.